By David Cassak
Published in the September 30, 2015 Issue (Vol. 2, No. 17)
Israel-based Sanara Ventures, backed by an alliance of unlikely partners, Teva and Philips, is mining the rich field of Israeli medtech start-ups, and hopes to offer a solution to a problem plaguing big companies today – the attrition of early-stage companies due to a lack of early-stage funding.
Kaleidoscope Medical—MGD—MEWay Pharma—Philips Medical Systems—Teva Pharmaceutical Industries Ltd.